SYT2 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 17 of 17 results for "SYT2"
i
  1. Structure of Botulinum neurotoxin B binding domain in complex with both synaptotagmin II and GD1a PDB

    ID: PDB:4KBB

    Description: Botulinum neurotoxin type B (E.C.3.4.24.69), Synaptotagmin-2

  2. Extended-Synaptotagmin 2, C2A- and C2B-domains PDB

    ID: PDB:4NPJ

    Description: Extended synaptotagmin-2

  3. Extended-Synaptotagmin 2, C2A- and C2B-domains, calcium bound PDB

    ID: PDB:4NPK

    Description: Extended synaptotagmin-2

  4. Binding domain of Botulinum neurotoxin DC in complex with rat synaptotagmin II PDB

    ID: PDB:4ISR

    Description: Neurotoxin, Synaptotagmin-2

  5. Extended-Synaptotagmin 2, SMP - C2A - C2B Domains PDB

    ID: PDB:4P42

    Description: E2

  6. Crystal structure of the Botulinum neurotoxin type B complexed with synaptotagamin-II ectodomain PDB

    ID: PDB:2NP0

    Description: Botulinum neurotoxin type B, EC 3.4.24.69, BoNT/B, Bontoxilysin-B (E.C.3.4.24.69), Synaptotagmin-2

  7. Crystal Structure of Synaptotagmin I C2A domain with Mn(II) PDB

    ID: PDB:3F05

    Description: Synaptotagmin-1

  8. Crystal Structure of Synaptotagmin I C2A domain with Cu(II) PDB

    ID: PDB:3F00

    Description: Synaptotagmin-1

  9. Crystal Structure of Synaptotagmin I C2A domain with Cu(II) PDB

    ID: PDB:3F01

    Description: Synaptotagmin-1

  10. SYT2_RAT UniProt:Swiss-Prot

    ID: P29101

    Description: Synaptotagmin-2 Vesicular Helical Cytoplasmic C2 1 C2 2 Phospholipid binding Calcium 2; via carbonyl oxygen Calcium 1 Calcium 2 Cal...

  11. Binding domain of Botulinum neurotoxin DC in complex with human synaptotagmin I PDB

    ID: PDB:4ISQ

    Description: Neurotoxin, Synaptotagmin-1

  12. Calmodulin controlled gene expression profiling in mouse cortical neruons BioProject

    ID: PRJNA130703

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: g these was a large increase in the expression of Syt2, which can serve as a Ca2+-sensor for synaptic exocytosis; thus, this upregulation of Syt2 by the CaM KD likely accounts for the rescue of the Syt1 KO phenotype. In addition, expression of Syb1 was massively increased, whereas expression of Syt4, Syt9, and syntaxin-1A was decreased. Another intriguing class of proteins whose expression was strongly regulated by CaM were cell-adhesion molecules, such as the synaptic cell-adhesion molecules Lrrtm1, Lrrtm3, and contactin-2. Moreover, we observed up-regulation of sodium channels, and a down-regulation of potassium channels, suggesting that CaM might control the activity-dependent regulation of neuronal excitability. Finally, we detected changes in multiple genes encoding transcription factors, intracellular signal transduction proteins, elements of the cytoskeleton, or metabolic enzymes. It should be noted, however, that despite these ...
  13. 737868 RGD

    Description: Congenic substrain which has a chromosome 13 segment from congenic SS/Jr.SR/Jr-Ren transferred to the SS/Jr recipient strain

    Creators: Medical College of Ohio, Toledo, Ohio, USA

    biologicalEntity.identifiers: SS.SR-(Syt2-D13Mit1)/Jr
  14. Gene expression profiles in rat mesenteric lymph nodes upon supplementation with conjugated linoleic acid during gestation and suckling ArrayExpress

    ID: E-GEOD-23004

    Description: or of metalloproteinase 1 (Timp1), galanin (Gal), synaptotagmin 1 (Syt1), growth factor receptor bound protein 2 (Grb2) actin gamma 2 (Actg2) and smooth muscle alpha actin (Acta2), as highly interconnected nodes of the resulting network. Gene underexpression was confirmed by Real-Time RT-PCR. We conclude that Ctgf, Timp1, Gal and Syt1, among others, are genes modulated by CLA supplementation that may have a role on lymphoproliferation and mucosal immune responses in early life. The aim of our study was to evaluate, by using whole genome microarrays, the effects of dietary supplementation with an 80:20 isomer mix of c9,t11 and t10,c12 CLA, respectively, on Mesentheric Lymph Nodes gene expression, during gestation and/or suckling. Three experimental approaches were conducted to assess the effects of CLA supplementation on I) pups from dams fed with 1% CLA diet during the two weeks of gestation and throughout the suckling period (Group A). These pups received CLA through the dam’s milk during suckling (Total Period of CLA Supplementation (TPS) 5 wk); II) pups from dams fed with 1% CLA diet during gestation and standard diet during suckling. These pups were CLA-supplemented daily during suckling by oral gavage (TPS 5 wk) (Group B); III) pups from dams fed standard diet during gestation and suckling and receiving CLA by daily oral gavage throughout the suckling period (TPS 3 wk) (Group C). Group D, pups from dams fed standard diet throughout the study, constituted the reference diet group (TPS 0 wk). Tri...

  15. 697 Retina

    Biological Entity: Horizontal cell, Astrocyte

    Molecular Entity: Syt2

  16. Gene expression profiles in rat mesenteric lymph nodes upon supplementation with conjugated linoleic acid during gestation and suckling BioProject

    ID: PRJNA129909

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: or of metalloproteinase 1 (Timp1), galanin (Gal), synaptotagmin 1 (Syt1), growth factor receptor bound protein 2 (Grb2) actin gamma 2 (Actg2) and smooth muscle alpha actin (Acta2), as highly interconnected nodes of the resulting network. Gene underexpression was confirmed by Real-Time RT-PCR. We conclude that Ctgf, Timp1, Gal and Syt1, among others, are genes modulated by CLA supplementation that may have a role on lymphoproliferation and mucosal immune responses in early life. Overall design: The aim of our study was to evaluate, by using whole genome microarrays, the effects of dietary supplementation with an 80:20 isomer mix of c9,t11 and t10,c12 CLA, respectively, on Mesentheric Lymph Nodes gene expression, during gestation and/or suckling. Three experimental approaches were conducted to assess the effects of CLA supplementation on I) pups from dams fed with 1% CLA diet during the two weeks of gestation and throughout the suckling period (Group A). These pups received CLA through the dam’s milk during suckling (Total Period of CLA Supplementation (TPS) 5 wk); II) pups from dams fed with 1% CLA diet during gestation and standard diet during suckling. These pups were CLA-supplemented daily during suckling by oral gavage (TPS 5 wk) (Group B); III) pups from dams fed standard diet during gestation and suckling and receiving CLA by daily oral gavage throughout the suckling period (TPS 3 wk) (Group C). Group D, pups from dams fed standard diet throughout the study, constituted the reference diet grou...
  17. Gene expression profiles in rat mesenteric lymph nodes upon supplementation with conjugated linoleic acid during gestation and suckling OmicsDI

    ID: E-GEOD-23004

    Date Released: 08-16-2011

    Description: or of metalloproteinase 1 (Timp1), galanin (Gal), synaptotagmin 1 (Syt1), growth factor receptor bound protein 2 (Grb2) actin gamma 2 (Actg2) and smooth muscle alpha actin (Acta2), as highly interconnected nodes of the resulting network. Gene underexpression was confirmed by Real-Time RT-PCR. We conclude that Ctgf, Timp1, Gal and Syt1, among others, are genes modulated by CLA supplementation that may have a role on lymphoproliferation and mucosal immune responses in early life. The aim of our study was to evaluate, by using whole genome microarrays, the effects of dietary supplementation with an 80:20 isomer mix of c9,t11 and t10,c12 CLA, respectively, on Mesentheric Lymph Nodes gene expression, during gestation and/or suckling. Three experimental approaches were conducted to assess the effects of CLA supplementation on I) pups from dams fed with 1% CLA diet during the two weeks of gestation and throughout the suckling period (Group A). These pups received CLA through the dam’s milk during suckling (Total Period of CLA Supplementation (TPS) 5 wk); II) pups from dams fed with 1% CLA diet during gestation and standard diet during suckling. These pups were CLA-supplemented daily during suckling by oral gavage (TPS 5 wk) (Group B); III) pups from dams fed standard diet during gestation and suckling and receiving CLA by daily oral gavage throughout the suckling period (TPS 3 wk) (Group C). Group D, pups from dams fed standard diet throughout the study, constituted the reference diet group (TPS 0 wk). Tri...


Displaying 17 of 17 results for "SYT2"